Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
Population-based precision cancer screening-letter. Gregson, E. Stachler, M. Loberg, M.
Institute of Oncology Ljubljana - Home
Benefits and harms of mammography screening. The role of pre-invasive disease in overdiagnosis: a microsimulation study comparing mass screening for breast cancer and cervical cancer. Saraiya, M. Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians. Dunn, B. Cancer prevention: lessons learned and future directions.
Trends Cancer 2 , — Kohler, C. Cell-free DNA in the circulation as a potential biomarker.
- Banks as Multinationals (RLE Banking & Finance) (Routledge Library Editions: Banking & Finance).
- Cervical Cancer: ESMO Clinical Practice Guidelines | ESMO.
- Radhika Srinivasan, M.D., Dip.N.B.E., Ph.D. profile in India Cancer Research Database.
- Pancreatic Cancer Center | NYU Langone Health.
Anticancer Res. Denduluri, N. Selection of optimal adjuvant chemotherapy regimens for human epidermal growth factor receptor 2 HER2 -negative and adjuvant targeted therapy for HER2-positive breast cancers: an american society of clinical oncology guideline adaptation of the cancer care ontario clinical practice guideline. Krop, I. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Onoclogy clinical practice guideline focused update.
Ascierto, P. Morris, V. BRAF inhibitors in clinical oncology. FPrime Rep. Kuo, C. Association between nonsteroidal anti-inflammatory drugs and colorectal cancer: a population-based case-control study. Biomarkers Prev. Drew, D. Aspirin and colorectal cancer: the promise of precision chemoprevention. Cancer 16 , — Kraus, S. Can we select patients for colorectal cancer prevention with aspirin?
Nan, H. Aspirin use, 8q24 single nucleotide polymorphismrs, and colorectal cancer according to CTNNB1 alterations. Natl Cancer Inst. JAMA , — Deng, X. Cancer precision medicine: from cancer screening to drug selection and personalized immunotherapy. Trends Pharmacol. Doubeni, C. Precision screening for colorectal cancer: promise and challenges.
Smith, R. Cancer screening in the United States, a review of current American Cancer Society guidelines and current issues in cancer screening. Imperiale, T.
- Jeremy Goes To Sunday School.
- Fine-needle aspiration cytology in the management of gynecologic oncology patients | SpringerLink.
- General Information About Cervical Cancer.
- Two Thirds Virgin Part 2.
Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Esserman, L. NPJ Breast Cancer 3 , 34 Shieh, Y. Breast cancer screening in the precision medicine era: risk-based screening in a population-based trial. Printz, C. Most women have an inaccurate perception of their breast cancer risk. Avital, I. Cancer 4 , — Le Magnen, C. Optimizing mouse models for precision cancer prevention.
Salvi, S. Cell-free DNA as a diagnostic marker for cancer: current insights. Targets Ther. Morelli, M. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Tie, J. Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. Nagpal, M. Tumor markers: a diagnostic tool.
- Cytopathology in Oncology | SpringerLink.
- Cancer prevention and screening: the next step in the era of precision medicine?
- Cervical Cancer: ESMO Clinical Practice Guidelines.
Qiao, Y. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. BMC Cancer 18 , Manzano, A. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?. ScientificWorldJournal , Cairns, J. The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks. Echizen, K. The inflammatory microenvironment that promotes gastrointestinal cancer development and invasion. Axelrad, J. Inflammatory bowel diesase and cancer: the role of inflammation, immunosuppression, and cancer treatment.
Yun Gong, MD
World J. Santos, S. Rothwell, P. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomized trials.
Lancet , — Multhoff, G. Chronic inflammation in cancer development. Nazarali, S. Tamoxifen for women at high risk of breast cancer. Breast Cancer Dove Med. Press 6 , 29—36 Crew, K. How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? NPJ Breast Cancer 3 , 20 Fisher, B. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breats and bowel project P-1 study. Cummings, S.
The effect of raloxifene on risk of breat cancer in postmenopausal women: results from the MORE randomized trial. Vogel, V. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Breast Cancer 3 , — AntiCancer Ther.
Rosenthal, E. Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients.